Add To...

    CSII  Cardiovascular Systems Inc.

    Exchange

    NASDAQ

    Sector

    Health Care

    Industry

    Medical/Dental Instruments

    Market Cap.

    410.2M

    Vuru Grade

    23.50/100

    Current Price

    $19.09
    +0.01 (+0.05%)

    Growth Price

    $-2.46
    Why is this negative?

    Stability Price

    $3.42
    Overvalued by 82.09%

    Company Overview

    Management
    Financial Strength
    Economic Moat
    Dividends & Buybacks

    Company Metrics

    • 0 P/E
    • 4.18 P/S
    • 5.86 P/B
    • -1.07 EPS
    • 44.07% Cash ROIC
    • 1.39 Cash Ratio
    • 0 / 0% Dividend
    • 197,345.00 Avg. Vol.
    • 15.92M Shares
    • 410.2M Market Cap.

    Company Description

    Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing interventional treatment systems for vascular disease. Its primary product, the Diamondback 360°, is a minimally invasive catheter system for the treatment of peripheral arterial disease and a range of plaque types in leg arteries. The Diamondback 360° consists of a single-use catheter that travels ...
    more


    Download 10 Years of Financial Statements:
    Income Statement   Balance Sheet   Cash Flow

    News

    Here is What Hedge Funds Think About Cardiovascular Systems Inc (CSII)
    Insider Monkey (blog) - Apr 19, 2013
    Cardiovascular Systems Inc (NASDAQ:CSII) has seen a decrease in enthusiasm from smart money of late. If you'd ask most traders, hedge funds are perceived as unimportant, old investment vehicles of yesteryear.
    CARDIOVASCULAR SYSTEMS INC : Cardiovascular Systems to Webcast Fiscal ...
    4-traders (press release) - Apr 24, 2013
    Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) will host a live webcast of its fiscal 2013 third-quarter conference call on Wednesday, May 1, 2013, at 3:45 p.m.
    Cardiovascular Systems Reports Fiscal 2013 Third-Quarter Financial Results
    DailyFinance - May 2, 2013
    Cardiovascular Systems, Inc. (CSI) (NAS: CSII) , a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal third quarter ended March 31, 2013.
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of ...
    GlobeNewswire (press release) - May 2, 2013
    NEW YORK, May 2, 2013 (GLOBE NEWSWIRE) -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP is investigating claims on behalf of investors of Cardiovascular Systems, Inc. ("Cardiovascular Systems" or the "Company") who purchased ...
    NASDAQ:CSII Long-Term Investor Alert: Investigation of Cardiovascular Systems ...
    Empowered News (press release) - May 14, 2013
    The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Cardiovascular Systems Inc (NASDAQ:CSII), was initiated concerning whether certain Cardiovascular Systems officers and directors possibly ...
    Tesla, Cardiovascular probed over stock trading plans: WSJ
    Fox Business - Apr 30, 2013
    A spokesman for Cardiovascular Systems told the Journal that the medical device company was readily providing the information requested.
    Insider-Trading Probe Trains Lens on Boards - Wall Street Journal
    Tesla among companies subpoenaed about director stock trades - Silicon Valley Business Journal
    Cardiovascular Systems Price Target Cut to $23.00 by Analysts at Benchmark ...
    Mideast Time - May 6, 2013
    Cardiovascular Systems (NASDAQ: CSII) had its target price cut by Benchmark Co. from $24.00 to $23.00 in a research note issued to investors on Thursday, AnalystRatings.
    Insiders Bought These Stocks on May-13 - Markets & Trade
    MarketsNTrade - May 14, 2013
    Cardiovascular Systems Inc is a medical device company, which is focused on developing and commercializing interventional treatment systems for vascular disease.
    Heart surgeon works on trial, presents for Verve Medical
    Phoenix Business Journal (blog) - 9 hours ago
    based Osprey Medical Inc. The Osprey Medical Cincor system is designed to remove contrast dye from the heart before it enters the kidneys and causes damage, known as contrast induced nephropathy, or CIN.
    Insiders Bought These Stocks on May-16 - Markets & Trade
    MarketsNTrade - May 17, 2013
    Cardiovascular Systems Inc is a medical device company, which is focused on developing and commercializing interventional treatment systems for vascular disease.